Compare Bio Protocol (BIO) vs Xertra (STRAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Xertra — how do they compare? Bio Protocol trades at Rp516.15 (market cap Rp1,15T, Rp264,79M 24h volume), while Xertra trades at Rp169.12 (market cap Rp368,16M, Rp176,87M 24h volume). The key difference: Bio Protocol is far larger — about 3123.6× Xertra's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Xertra's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Xertra for 38 Days on average.
| BIO | STRAX | |
|---|---|---|
Market Cap | Rp1,15T | Rp368,16M |
Volume (24h) | Rp264,79M | Rp176,87M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 2,2B STRAX |
Typical Hold Time | 16 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
STRAX is currently trading at Rp169.48 with a market cap of Rp365.65M, showing a bullish technical signal overall despite bearish moving averages. The token trades near support at Rp164 with resistance at Rp184, while ADX indicators suggest strong trend momentum. With a 38-day average hold time indicating moderate holding patterns, the asset shows technical strength but limited recent fundamental developments.
Overall outlook remains cautiously optimistic given the bullish technical setup, though limited ecosystem activity and low market cap present both opportunity for growth and liquidity risks. Key risks include low trading volume and regulatory uncertainty in the crypto space, while potential upside exists if technical momentum translates to broader market interest.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Xertra
Stratis is a blockchain-as-a-service platform that offers several products and services for enterprises, including launching private sidechains, running full nodes, developing and deploying smart contracts, an initial coin offering platform, and a proof-of-identity application. The company also provides cryptocurrency wallets and blockchain consulting services.
Read more on STRAX →
